BromAc is an Australian drug treatment that has the potential to stop COVID-19 in its tracks. Currently under test, the treatment is a readily scalable opportunity to minimise the impact of the virus while a vaccine is developed.
Headquarters:
Australia
Company Type:
SME
Company size:
11-50 Employees
Address:
L3 PITNEY BUILDING, SHORT STREET; SYDNEY, NEW SOUTH WALES 2000, AU
LOW
spending power